Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 79
Appendix D
Registered Attendees
Reza Alavi Bruce Blumberg
Center for Medical Technology Kaiser Permanente
Policy
Juli Bollinger
William Albuquerque Genetics and Public Policy Center
Genetic Alliance
Denise Bonds
C. Anthony Altar National Heart, Lung, and Blood
AssureRx Health, Inc. Institute
Eric Assaraf Khaled Bouri
Washington Research Group U.S. Food and Drug
Administration
David Bachinsky
Chandra Branham
Alpha-Genics
AdvaMed
Judith Benkendorf
Joel Brill
American College of Medical
Genetics and Genomics Predictive Health, LLC
Sharon Bergquist Steven Brotman
National Academy of Sciences AdvaMed
Paul Billings Jonca Bull
Life Technologies Novartis
79
OCR for page 80
80 GENOME-BASED DIAGNOSTICS
Wylie Burke Jonathan Gitlin
University of Washington National Human Genome Research
Institute
Khatereh Calleja
Judith Glassgold
AdvaMed
Office of Rep. Sander Levin
C. Thomas Caskey
Joseph Glick
Baylor College of Medicine
Expertool Software
Niranjana Chandrasekaran
Federico Goodsaid
Genetic Alliance
Vertex Pharmaceuticals
John Cogswell
Mark Gorman
Bristol-Myers Squibb
National Coalition for Cancer
Nicholas Conti Survivorship
Quest Diagnostics
Johanna Gray
Sara Copeland CRD Associates
Health Resources and Services
David Gross
Administration
College of American Pathologists
Amy Cunniffe
Alberto Gutierrez
Caris Life Sciences
U.S. Food and Drug
Bernard Edelman Administration
Vietnam Veterans of America
Chris Havasy
Russel Enns Presidential Commission for the
Cepheid Study of Bioethical Issues
W. Gregory Feero Daniel Hayes
National Human Genome Research University of Michigan
Institute Comprehensive Cancer Center
Andrew Freedman C. J. Hoban
National Cancer Institute Multiple Myeloma Research
Foundation
Geoffrey Ginsburg
Louis Hochheiser
Duke University
Humana, Inc.
OCR for page 81
81
APPENDIX D
Richard Hodes Emily Lenneville
National Institute on Aging Institute of Medicine
Gillian Hooker Debra Leonard
National Human Genome Research Weill Cornell Medical Center
Institute
Hallie Lewis
Louis Jacques Cepheid
Centers for Medicare & Medicaid
Rachel Lindor
Services
Department of Health and Human
Janet Jenkins-Showalter Services
Roche/Genentech
Kimberly Linthicum
Michael Evan Johnson Myriad Genetic Laboratories
SWIDE Effects LLC
Paul Lipkin
Sharon Kardia Kennedy Krieger Institute
University of Michigan
Michele Lloyd-Puryear
James Kelly Office of Rare Diseases Research,
Affymetrix National Institutes of Health
Mohamed Khan Jenny Luray
Vancouver Cancer Centre BD
Christopher Khoury Anthony Magliocco
PwC H. Lee Moffitt Cancer Center
Muin Khoury Debra Mathews
Centers for Disease Control and Presidential Commission for the
Prevention Study of Bioethical Issues
Vanessa King Robert McCormack
Siemens Corporate Research Veridex, LLC
Brenda Kostelecky Mary McGrane
National Cancer Institute U.S. Department of Agriculture
Jennifer Leib Kasinathan Muralidharan
HealthFutures, LLC Quest Diagnostics Nichols Institute
OCR for page 82
82 GENOME-BASED DIAGNOSTICS
Rachel Novak Turna Ray
U.S. Food and Drug GenomeWeb
Administration
Michael Reiner
Robert Nussbaum Siemens Healthcare
University of California, San
Stephen Richardson
Francisco, School of Medicine
Genomic Health, Inc.
Steve Olson
Allen Roses
Independent Consultant
Duke University
Danielle Pambianco
Tharini Sathiamoorthy
HillCo HEALTH
AdvaMedDx
Meeta Patnaik
Manon Schladen
Transtek Clinical Systems
Medstar Health Research Institute
Mary Pendergast
Kevin Schulman
Pendergast Consulting
Duke University Medical Center
Michelle Penny
Joan Scott
Eli Lilly and Company
National Coalition for Health
Margaret Piper Professional Education in
Blue Cross and Blue Shield Genetics
Association
Beverlyn Settles-Reaves
Laura Povlich Howard University
American Association for the
Steven Shak
Advancement of Science
Congressional Fellow—Office Genomic Health, Inc.
of Rep. Sander Levin
Fay Shamanski
Aidan Power College of American Pathologists
Pfizer Inc.
Marilee Shelton-Davenport
Bruce Quinn National Research Council
Foley Hoag LLP
Sophie Shen
Scott Rabuka The Brookings Institution
DNA Genotek
Vaidehi Sheth
Genetic Alliance
OCR for page 83
83
APPENDIX D
Andy Shih Michael S. Watson
Autism Speaks American College of Medical
Genetics and Genomics
Sue Siegel
Jennifer Webster
Mohr Davidow
Kaiser Permanente Center for
Jennifer Skornik Heath Research
Independent
Susan Weiner
Dennis Strickland Children’s Cause for Cancer
Pfizer Inc. Advocacy
Katherine Johansen Taber Cole Werble
American Medical Association The RPM Report
Wendy Toler Catherine Wicklund
Medscientia Northwestern University
Sean Tunis Yining Xie
Center for Medical Technology National Institutes of Health
Policy
Huichun Xu
Martha Turner National Institutes of Health
American Nurses Association
Jiwen Zhang
Laura van ‘t Veer GE Healthcare
University of California, San
Francisco, Helen Diller Family
Comprehensive Cancer Center
OCR for page 84
